Clinical Trials Insight: 700027956
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2008
At a glance
- Drugs Vorapaxar (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Sponsors Schering-Plough
- 30 Aug 2008 Results were presented at the 2008 European Society of Cardiology meeting.
- 30 Oct 2007 New trial record.